跳至主要内容
临床试验/ITMCTR1900002318
ITMCTR1900002318
招募中
未知

Multicenter randomized controlled clinical trial for therapeutic Evaluation of TCM in patients with extensive small cell lung cancer (SCLC)

Beijing Hospital of TCM, Capital Medical University0 个研究点待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
extensive small cell lung cancer
发起方
Beijing Hospital of TCM, Capital Medical University
状态
招募中
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional study
性别
All

研究者

发起方
Beijing Hospital of TCM, Capital Medical University

入排标准

入选标准

  • (1\) patients diagnosed with small cell lung cancer by cytology or histology with distant organ metastasis and/or lymph node metastasis of the contralateral hilar lung in extensive stage (via cranial MRI, chest CT, bone scan, abdominal CT or PET/CT);
  • (2\) did not receive radiotherapy, chemotherapy or surgical treatment, with evaluable lesions;
  • (3\) ECOG score 2, and the expected survival time is \> for 3 months;
  • (4\) aged 18\-75 years, with serious diseases of heart, brain, kidney, liver, blood and other systems;
  • (5\) agree to participate in this study and sign the informed consent.

排除标准

  • (1\) massive pleural or peritoneal effusion or pericardial effusion causes dyspnea;
  • (2\) symptomatic bone metastases requiring radiotherapy;
  • (3\) brain metastasis;
  • (4\) pregnant or lactating women, or serious diseases of heart, lung, liver, kidney, blood and other systems;
  • (5\) patients who are known to be allergic to the study drugs;
  • (6\) patients undergoing other drug trials.

结局指标

主要结局

未指定

相似试验